Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Belantamab mafodotin[1] Belantamab mafodotin (Belantamab mafodotin)[1] Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[2] 28, 63 💬
2Belantamab mafodotin 1.0 mg/kg (12 weeks)[1] Belantamab mafodotin (Belantamab mafodotin)[1] Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
3Belantamab mafodotin 1.4 mg/kg (12 weeks)[1] Belantamab mafodotin (Belantamab mafodotin)[1] Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
4Belantamab mafodotin 1.9 mg/kg (12 weeks)[1] Belantamab mafodotin (Belantamab mafodotin)[1] Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
5Belantamab mafodotin 1.9 mg/kg (8 weeks)[1] Belantamab mafodotin (Belantamab mafodotin)[1] Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
6Belantamab mafodotin 2.5 mg/kg (8 weeks)[1] Belantamab mafodotin (Belantamab mafodotin)[1] Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬
7Belantamab mafodotin every 8 weeks or 12 weeks as determined by Part 1 recommended dosages[1] Belantamab mafodotin (Belantamab mafodotin)[1] Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 [10] TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[14] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 28 💬